Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Core Laboratories (CLB) EBITDA (2022 - 2025)

Core Laboratories (CLB) has 4 years of EBITDA data on record, last reported at $24.5 million in Q3 2025.

  • For Q3 2025, EBITDA rose 4.72% year-over-year to $24.5 million; the TTM value through Sep 2025 reached $20.0 million, down 72.79%, while the annual FY2024 figure was $24.0 million, 65.68% down from the prior year.
  • EBITDA reached $24.5 million in Q3 2025 per CLB's latest filing, up from $18.9 million in the prior quarter.
  • Across five years, EBITDA topped out at $24.5 million in Q3 2025 and bottomed at -$31.3 million in Q4 2024.
  • Average EBITDA over 4 years is $14.1 million, with a median of $18.6 million recorded in 2022.
  • The widest YoY moves for EBITDA: up 26.42% in 2024, down 270.73% in 2024.
  • A 4-year view of EBITDA shows it stood at $19.5 million in 2022, then dropped by 6.12% to $18.3 million in 2023, then crashed by 270.73% to -$31.3 million in 2024, then surged by 178.16% to $24.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBITDA were $24.5 million in Q3 2025, $18.9 million in Q2 2025, and $8.0 million in Q1 2025.